111 related articles for article (PubMed ID: 3890216)
21. Overview on the pharmacological and toxicological characterization of the calcium antagonist tiapamil.
Haeusler G; Eigenmann R; Gerold M; Hefti F; Jovanovic D; Blaber L; Nakamura K; Thorens S
Cardiology; 1982; 69 Suppl():31-57. PubMed ID: 7151083
[No Abstract] [Full Text] [Related]
22. Efficacy and tolerability of tiapamil in patients with mild to moderate essential hypertension.
Lacourcière Y; Carrier M; Toal CB
J Cardiovasc Pharmacol; 1989 Jul; 14(1):166-70. PubMed ID: 2475708
[TBL] [Abstract][Full Text] [Related]
23. Effects of tiapamil on haemodynamics and myocardial salvage during myocardial infarction in the baboon.
Rogers GG; Rosendorff C; Shimell CJ; Coull A
Cardiology; 1982; 69 Suppl():58-67. PubMed ID: 7151084
[TBL] [Abstract][Full Text] [Related]
24. Negative inotropic effects of tiapamil (Ro11-1781) and verapamil in rabbit myocardium.
Harada S; Sada H; Kojima M; Ban T
Eur J Pharmacol; 1982 Feb; 78(1):7-14. PubMed ID: 7075665
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological investigation of a new anti-arrhythmic agent, GYKI-23 107.
Varró A; Rabloczky G; Jaszlits L; Kürthy M; Zubovics Z; Toldy L
Drugs Exp Clin Res; 1987; 13(1):21-8. PubMed ID: 3595441
[TBL] [Abstract][Full Text] [Related]
26. Antihypertensive properties of tiapamil (RO 11-1781)--a new calcium antagonist--in patients with mild and moderate essential hypertension.
Velasco M; Morillo J; Urbina A; Kögler P; Leishman B; Pasquier M; Hernändez-Pieretti O
Int J Clin Pharmacol Res; 1987; 7(6):443-54. PubMed ID: 3440635
[TBL] [Abstract][Full Text] [Related]
27. Chronic administration of tiapamil prevents hemodynamic alterations accompanying development of high blood pressure in hypertensive rats.
Hefti F; Gerold M; Holck M
J Cardiovasc Pharmacol; 1984; 6(6):1192-200. PubMed ID: 6084779
[TBL] [Abstract][Full Text] [Related]
28. Verapamil and tiapamil in prevention of ventricular fibrillation in pigs with coronary ligation. Comparative effects on left ventricular function.
Muller CA; Opie LH; Hamm CW; Peisach M; Pineda CA; Thandroyen FT
Circulation; 1988 Jul; 78(1):227-32. PubMed ID: 3383406
[TBL] [Abstract][Full Text] [Related]
29. Tiapamil, a new calcium antagonist. 2. Further pharmacological characterization and toxicology.
Eigenmann R; Gerold M; Hefti F; Jovanovic D; Haeusler G
Arzneimittelforschung; 1981; 31(9):1401-10. PubMed ID: 7197946
[No Abstract] [Full Text] [Related]
30. Efficacy of incremental doses of tiapamil on exercise performance in patients with chronic stable angina pectoris.
O'Keefe JC; Maltz MB; Butrous GS; Camm AJ
Eur Heart J; 1986 Oct; 7(10):843-7. PubMed ID: 3539614
[TBL] [Abstract][Full Text] [Related]
31. Effects of tiapamil, a new calcium channel blocker, on ambulatory intraarterial blood pressure and exercise-induced changes in blood pressure.
Caruana M; Al-Khawaja I; Prince H; Raftery EB
J Cardiovasc Pharmacol; 1986; 8(5):1074-7. PubMed ID: 2429082
[TBL] [Abstract][Full Text] [Related]
32. Effect of tiapamil on perioperative cardiac arrhythmias and myocardial function.
List WF; Metzler H
Cardiology; 1982; 69 Suppl():157-64. PubMed ID: 6185222
[TBL] [Abstract][Full Text] [Related]
33. Effect of tiapamil on canine myocardial infarct size.
Kordenat K; Leasure J
Am Heart J; 1986 Mar; 111(3):502-12. PubMed ID: 3953359
[TBL] [Abstract][Full Text] [Related]
34. Tiapamil, Ro 11-1781, a Ca++ antagonist. An improved synthesis, physiochemical properties, preparation of a deuterated derivative.
Ramuz H
Cardiology; 1982; 69 Suppl():26-30. PubMed ID: 7151082
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and hemodynamic effects of tiapamil: exercise performance, thallium stress scintigraphy, and radionuclide ventriculography.
Eckert M; Pozenel H; Pillat B
J Clin Pharmacol; 1984 Apr; 24(4):165-73. PubMed ID: 6725618
[TBL] [Abstract][Full Text] [Related]
36. Protective effect of tiapamil against ventricular fibrillation during coronary artery occlusion.
Raeder EA; Verrier RL; Lown B
Am Heart J; 1986 May; 111(5):878-82. PubMed ID: 3706107
[TBL] [Abstract][Full Text] [Related]
37. Antihypertensive effect of tiapamil, a calcium antagonist. Double-blind placebo crossover study.
Chu D; De Gori D
Cardiology; 1982; 69 Suppl():99-104. PubMed ID: 6758935
[TBL] [Abstract][Full Text] [Related]
38. [Management of supraventricular and ventricular arrhythmias with the intravenous administration of the calcium antagonist Tiapamil (Ro 11-1781) (author's transl)].
Menzel T; Kirchner P; Cocco G; Gasser DF
Z Kardiol; 1981 Mar; 70(3):163-71. PubMed ID: 6165153
[TBL] [Abstract][Full Text] [Related]
39. Renal effects of calcium blockade by tiapamil in normal and hypertensive subjects.
Ribstein J; Cristol JP; Elkik F; Mimran A
J Hypertens Suppl; 1985 Dec; 3(3):S165-7. PubMed ID: 2856696
[TBL] [Abstract][Full Text] [Related]
40. Effect of propionyl-L-carnitine on experimental myocardial infarction in dogs.
Leasure JE; Kordenat K
Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():85-95. PubMed ID: 2031876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
